CD40LG and type 1 diabetes mellitus: A similar strategy currently being studied in NOD mice is Pentaglobin treatment, a human immunoglobulin preparation enriched in IgM, which led to the expansion of thymic B cells and regulatory T cells (Tregs) and short-term reversal of T1D in ~78% of mice enrolled in the study [163].